Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question

Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question

Immunotherapy has redefined the treatment of cancer patients and it is constantly generating new advances and approaches. Among the multiple options of immunotherapy, bispecific antibodies (bsAbs) represent a novel thoughtful approach. These drugs integrate the action of the immune system in a strat...

Full description

Bibliographic Details
Main Authors: Camila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, Diego F. Chamorro, Andrés Mosquera, Liliana Sussmann, Alejandro Ruiz-Patiño, Oscar Arrieta, Lucia Zatarain-Barrón, Leonardo Rojas, Alessandro Russo, Diego de Miguel-Perez, Christian Rolfo, Andrés F. Cardona
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Pharmaceutics
Subjects:
bispecific antibodies
immunotherapy
immune restoration
cancer therapy
Online Access:https://www.mdpi.com/1999-4923/14/6/1243

Internet

https://www.mdpi.com/1999-4923/14/6/1243

Similar Items